DNAJB6 and acute myeloid leukemia: AML patient sample 990 was the most responsive, with a greater percentage of apoptosis, 30–40%, observed relative to the untreated cells, with low concentrations of DJ4 treatment (0.5–1 μM) than the other AML primary cases (Figure 3B and Figure S4).